PD 153035 hydrochloride

Name: PD 153035 hydrochloride
Brand: Tocris Bioscience
SKU: 1037

Tocris Bioscience a Bio-Techne Brand

Catalog # 1037

Citations (5)

COA / SDS

Catalog #

Availability

Size / Price

Qty

Key Product Details

Description:	EGFR-kinase inhibitor
Alternative Names:	ZM 252868
Chemical Name:	4-[(3-Bromophenyl)amino]-6,7-dimethoxyquinazoline hydrochloride
Molecular Weight:	396.67

View Full Technical Details for PD 153035 hydrochloride

Complete Your Research

Biological Activity for PD 153035 hydrochloride

An extremely potent inhibitor of epidermal growth factor (EGF) receptor tyrosine kinase, with an IC₅₀ of 25 pM. Inhibits other purified tyrosine kinases only at micromolar or higher concentrations.

Licensing Information

Sold with the permission of AstraZeneca UK Ltd.

Technical Data for PD 153035 hydrochloride

M. Wt	396.67
Formula	C₁₆H₁₄BrN₃O₂.HCl
Storage	Store at RT
CAS Number	183322-45-4
PubChem ID	11246488
InChi Key	ZJOKWAWPAPMNIM-UHFFFAOYSA-N
Smiles	BrC1=CC=CC(NC3=NC=NC2=CC(OC)=C(OC)C=C23)=C1.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility for PD 153035 hydrochloride

	Solvent	Max Conc. mg/mL	Max Conc. mM
Solubility
Solubility	DMSO	3.97	10 with gentle warming

Preparing Stock Solutions for PD 153035 hydrochloride

The following data is based on the product molecular weight 396.67.

Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	25.21 mL	126.05 mL	252.10 mL
0.5 mM	5.04 mL	25.21 mL	50.42 mL
1 mM	2.52 mL	12.60 mL	25.21 mL
5 mM	0.50 mL	2.52 mL	5.04 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt*

g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1 (C1)

Volume 1 (V1)

Concentration 2 (C2)

Volume 2 (V2)

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

References for PD 153035 hydrochloride

References are publications that support the biological activity of the product.

Bos PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin.Cancer Res. 1997 PMID: 9815602
Bridges Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J.Med.Chem. 1996 PMID: 8568816
Fry A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 1994 PMID: 8066447

Citations for PD 153035 hydrochloride (5)

Showing 1 - 5 of 5 citations Showing All

Search Title:

Citations are publications that use Bio-Techne products. Selected citations for PD 153035 hydrochloride include:

Marshall et al. (2018) Analysis of the Intrinsic Self-Organising Properties of Mesenchymal Stromal Cells in Three-Dimensional Co-Culture Models with Endothelial Cells. Bioengineering (Basel). 5
PMID: 30373192
Lahey et al. (2017) Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function. PLoS One. 12:e0180259
PMID: 28671992
Taylor et al. (2014) Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition. Breast Cancer Res Treat. 144:551
PMID: 24610032
Swanson et al. (2012) Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis. J Immunol. 188:3513
PMID: 22393153
Xu (2007) EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res. 67:6121
PMID: 17616668

There are no citations that match your criteria.